OLYS Pharma

La Hulpe ·KBO/BCE: BE 0754.895.372

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	54.7%	46.9%	better than 53% of 46 sector peers
Net result	€534k	€-1k	better than 92% of 46 sector peers
Equity	€565k	€108k	better than 71% of 46 sector peers
Gross operating margin	€635k	€28k	better than 90% of 42 sector peers
Total assets	€1.03M	€284k	better than 64% of 46 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.03M
Fixed assets	21/28	€840k
Formation expenses	20	€228
Intangible fixed assets	21	€840k
Tangible fixed assets	22/27	€408
Current assets	29/58	€192k
Stocks & contracts in progress	3	€7k
Amounts receivable within one year	40/41	€18k
Cash & bank	54/58	€167k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.03M
Equity	10/15	€565k
Contributions / capital	10/11	€496k
Accumulated profits (losses)	14	€-106k
Amounts payable	17/49	€468k
Amounts payable after one year	17	€200k
Amounts payable within one year	42/48	€268k
Trade debts payable within one year	44	€17k
Income statement
Gross operating margin	9900	€635k
Operating result	9901	€545k
Financial income	75	€5k
Financial charges	65	€16k
Result before taxes	9903	€534k
Net result for the period	9904	€534k
Result to be appropriated	9905	€534k

Summary